Fig. 3From: Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literatureSerum estrogen level quantified at pre– and post–mesenchymal stem cell ovarian implantation. The arrow indicates the menses that resume within 7 months following mesenchymal stem cell engraftmentBack to article page